Product Image

Contributor Information

  • Institute Versiti Blood Research Institute

Tool Details

  • Tool name: Anti-AvW-5 (von Willebrand Factor) [MBC 121.1]
  • Alternate names: vWf
  • Tool type: Antibodies
  • Tool sub-type: Primary Antibody
  • Class: Monoclonal
  • Conjugate: Unconjugated
  • Reactivity: Dog ; Human
  • Host: Mouse
  • Molecular weight of the target: 293 kDa
  • Application: ELISA ; IF ; IP ; WB
  • Description: Von Willebrand factor (vWF) is a multimeric plasma glycoprotein that functions in hemostasis as the initiator of platelet adhesion at the site of vascular injury and as the carrier of the anti-hemophilic factor, factor VIII (FVIII). Hereditary or acquired defects of VWF lead to von Willebrand disease (vWD), a bleeding diathesis of the skin and mucous membranes, causing nosebleeds, menorrhagia, and gastrointestinal bleeding.
  • Immunogen: vWf - epitope lies on the C-terminal end of VWF
  • Research area: Immunology
  • Myeloma used: P3X63Ag8.653

  • For Research Use Only

Target Details

  • Target: von Willebrand Factor
  • Target molecular weight: 293 kDa
  • Target background: Von Willebrand factor (vWF) is a multimeric plasma glycoprotein that functions in hemostasis as the initiator of platelet adhesion at the site of vascular injury and as the carrier of the anti-hemophilic factor, factor VIII (FVIII). Hereditary or acquired defects of VWF lead to von Willebrand disease (vWD), a bleeding diathesis of the skin and mucous membranes, causing nosebleeds, menorrhagia, and gastrointestinal bleeding.

Application Details

  • Application: ELISA ; IF ; IP ; WB

Handling

  • Format: Liquid
  • Concentration: 0.9-1.1 mg/ml
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15°C to -25°C
  • Shipping conditions: Shipping at 4°C

Documentation

References

  •   Jacobi et al. 2012. Blood. 119(19):4543-53. PMID: 22431572.
  •   Haberichter et al. 2005. Blood. 105(1):145-52. PMID: 15331450.
  •   Haberichter et al. 2000. Blood. 96(5):1808-15. PMID: 10961880.
  •   Rosenberg et al. 1998. J Clin Invest. 101(3):613-24. PMID: 9449695.